117TH CONGRESS 

1ST SESSION H. R. 1550 

AN ACT 

To amend the Public Health Service Act to provide for 

a public awareness campaign with respect to human 

papillomavirus, and for other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 
2 

•HR 1550 EH

1 SECTION 1. SHORT TITLE. 

2 This Act may be cited as the ‘‘Promoting Resources 

3 to Expand Vaccination, Education, and New Treatments 

4 for HPV Cancers Act of 2021’’ or the ‘‘PREVENT HPV 

5 Cancers Act of 2021’’. 

6 SEC. 2. PREVENTING HPV AND HPV-ASSOCIATED CANCERS; 

7 REAUTHORIZING JOHANNA’S LAW. 

8 Section 317P of the Public Health Service Act (42 

9 U.S.C. 247b–17) is amended— 

10 (1) in subsection (c)(1)— 

11 (A) in subparagraph (B), by striking ‘‘cer12 vical’’; 

13 (B) in subparagraph (C), by striking 

14 ‘‘and’’ at the end; 

15 (C) in subparagraph (D) by striking 

16 ‘‘other’’ and all that follows through ‘‘cancer.’’ 

17 and inserting ‘‘recommended diagnostics for 

18 early intervention for, and prevention of, HPV19 associated cancers; and’’; and 

20 (D) by adding at the end the following: 

21 ‘‘(E) the importance of recommended vac22 cines for prevention of HPV and HPV-associ23 ated cancers, including for males;’’; and 

24 (2) by amending subsection (d) to read as fol25 lows: 

26 ‘‘(d) JOHANNA’S LAW.— 
3 

•HR 1550 EH

1 ‘‘(1) NATIONAL PUBLIC AWARENESS CAM2 PAIGN.— 

3 ‘‘(A) IN GENERAL.—The Secretary shall 

4 carry out a national campaign to increase the 

5 awareness and knowledge of health care pro6 viders and individuals with respect to 

7 gynecologic cancers, HPV, and HPV-associated 

8 cancers, and the importance of HPV vaccines in 

9 preventing HPV and HPV-associated cancers. 

10 ‘‘(B) WRITTEN MATERIALS.—Activities 

11 under the national campaign under subpara12 graph (A) shall include— 

13 ‘‘(i) maintaining a supply of written 

14 materials that provide information to the 

15 public on gynecologic cancers, HPV, and 

16 HPV-associated cancers; and 

17 ‘‘(ii) distributing the materials to 

18 members of the public upon request. 

19 ‘‘(C) PUBLIC SERVICE ANNOUNCE20 MENTS.—Activities under the national cam21 paign under subparagraph (A) shall, in accord22 ance with applicable law and regulations, in23 clude publishing materials in digital or print 

24 form, public engagement, and developing and 

25 placing public service announcements intended 
4 

•HR 1550 EH

1 to encourage individuals to discuss with their 

2 physicians— 

3 ‘‘(i) their risk of gynecologic cancers 

4 and HPV-associated cancers; and 

5 ‘‘(ii) the importance of HPV vaccines 

6 in preventing HPV and HPV-associated 

7 cancers. 

8 ‘‘(D) TARGETED POPULATIONS.—Activities 

9 under the national campaign under subpara10 graph (A) shall include culturally and linguis11 tically competent public service announcements 

12 and other forms of communication and public 

13 engagement under subparagraph (C) targeted 

14 to— 

15 ‘‘(i) specific higher-risk populations of 

16 individuals based on race, ethnicity, level of 

17 acculturation, and family history, including 

18 African-American and Ashkenazi Jewish 

19 individuals; 

20 ‘‘(ii) communities with high rates of 

21 unvaccinated individuals, including males; 

22 ‘‘(iii) rural communities; 

23 ‘‘(iv) populations affected by increas24 ing rates of oropharynx cancers; 
5 

•HR 1550 EH

1 ‘‘(v) health care providers specializing 

2 in assisting survivors of sexual assault; and 

3 ‘‘(vi) such other communities as the 

4 Secretary determines appropriate. 

5 ‘‘(2) CONSULTATION.—In carrying out the na6 tional campaign under this section, the Secretary 

7 shall consult with— 

8 ‘‘(A) health care providers; 

9 ‘‘(B) nonprofit organizations (including 

10 gynecologic cancer organizations and organiza11 tions that represent communities and individ12 uals most affected by HPV-associated cancers 

13 and low vaccination rates); 

14 ‘‘(C) State and local public health depart15 ments; and 

16 ‘‘(D) elementary and secondary education 

17 organizations and institutions of higher edu18 cation. 

19 ‘‘(3) DEMONSTRATION PROJECTS REGARDING

20 OUTREACH AND EDUCATION STRATEGIES.— 

21 ‘‘(A) IN GENERAL.— 

22 ‘‘(i) PROGRAM.—The Secretary may 

23 carry out a program to award grants or 

24 contracts to public or nonprofit private en25 tities for the purpose of carrying out dem-
6 

•HR 1550 EH

1 onstration projects to test, compare, and 

2 evaluate different evidence-based outreach 

3 and education strategies to increase the 

4 awareness and knowledge of women, their 

5 families, physicians, nurses, and other key 

6 health professionals with respect to 

7 gynecologic cancers, including with respect 

8 to early warning signs, risk factors, pre9 vention, screening, and treatment options. 

10 ‘‘(ii) SCIENCE-BASED RESOURCES.— 

11 In making awards under clause (i), the 

12 Secretary shall encourage awardees to use 

13 science-based resources such as the Inside 

14 Knowledge About Gynecologic Cancer edu15 cation campaign of the Centers for Disease 

16 Control and Prevention. 

17 ‘‘(B) PREFERENCES IN AWARDING GRANTS

18 OR CONTRACTS.—In making awards under sub19 paragraph (A), the Secretary shall give pref20 erence to— 

21 ‘‘(i) applicants with demonstrated ex22 pertise in gynecologic cancer education or 

23 treatment or in working with groups of 

24 women who are at increased risk of 

25 gynecologic cancers; and 
7 

•HR 1550 EH

1 ‘‘(ii) applicants that, in the dem2 onstration project funded by the grant or 

3 contract, will establish linkages between 

4 physicians, nurses, other key health profes5 sionals, health profession students, hos6 pitals, payers, and State health depart7 ments. 

8 ‘‘(C) APPLICATION.—To seek a grant or 

9 contract under subparagraph (A), an entity 

10 shall submit an application to the Secretary in 

11 such form, in such manner, and containing such 

12 agreements, assurances, and information as the 

13 Secretary determines to be necessary to carry 

14 out this paragraph. 

15 ‘‘(D) CERTAIN REQUIREMENTS.—In mak16 ing awards under subparagraph (A), the Sec17 retary shall— 

18 ‘‘(i) make awards, as practicable, to 

19 not fewer than five applicants; and 

20 ‘‘(ii) ensure that information provided 

21 through demonstration projects under this 

22 paragraph is consistent with the best avail23 able medical information. 

24 ‘‘(E) REPORT TO CONGRESS.—Not later 

25 than 24 months after the date of the enactment 
8 

•HR 1550 EH

1 of the PREVENT HPV Cancers Act of 2021, 

2 and annually thereafter, the Secretary shall 

3 submit to the Committee on Energy and Com4 merce of the House of Representatives and the 

5 Committee on Health, Education, Labor, and 

6 Pensions of the Senate a report that— 

7 ‘‘(i) summarizes the activities of dem8 onstration projects under subparagraph 

9 (A); 

10 ‘‘(ii) evaluates the extent to which the 

11 projects were effective in increasing aware12 ness and knowledge of risk factors and 

13 early warning signs in the populations to 

14 which the projects were directed; and 

15 ‘‘(iii) identifies barriers to early detec16 tion and appropriate treatment of such 

17 cancers. 

18 ‘‘(4) AUTHORIZATION OF APPROPRIATIONS.— 

19 For the purpose of carrying out this subsection, 
9 

•HR 1550 EH

1 there is authorized to be appropriated $25,000,000 

2 for the period of fiscal years 2022 through 2026.’’. 

Passed the House of Representatives November 30, 

2021. 

Attest: 

Clerk. 
117TH CONGRESS 

1ST SESSION H. R. 1550 

AN ACT 

To amend the Public Health Service Act to provide 

human papillomavirus, and for other purposes. for a public awareness campaign with respect to